• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黎巴嫩血液透析患者中由专业营养师管理高磷血症的成本效益:骨营养不良管理营养教育试验的结果

Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial.

作者信息

Rizk Rana, Hiligsmann Mickaël, Karavetian Mirey, Evers Silvia M A A

机构信息

a Department of Health Services Research , CAPHRI, Care and Public Health Research Institute, Maastricht University , Maastricht , The Netherlands.

b Department of Health Sciences, College of Natural and Health Sciences , Zayed University , Dubai , United Arab Emirates.

出版信息

J Med Econ. 2017 Oct;20(10):1024-1038. doi: 10.1080/13696998.2017.1347877. Epub 2017 Jul 13.

DOI:10.1080/13696998.2017.1347877
PMID:28657451
Abstract

AIM

To assess the cost-effectiveness of nutrition education by dedicated dietitians (DD) for hyperphosphatemia management among hemodialysis patients.

MATERIALS AND METHODS

This was a trial-based economic evaluation in 12 Lebanese hospital-based units. In total, 545 prevalent patients were cluster randomized to DD, trained hospital dietitian (THD), and existing practice (EP) groups. During Phase I (6 months), DD (n = 116) received intensive education by DD trained on renal nutrition, THD (n = 299) received care from trained hospital dietitians, and EP (n = 130) received usual care from untrained hospital dietitians. Patients were followed-up during Phase II (6 months).

RESULTS

At baseline, EP had the lowest weekly hemodialysis time, and DD had the highest serum phosphorus and malnutrition-inflammation score. The additional costs of the intervention were low compared with the societal costs (DD: $76.7, $21,007.7; EP: $4.6, $18,675.4; THD: $17.4, $20,078.6, respectively). Between Phases I and II, DD showed the greatest decline in services use and societal costs (DD: -$2,364.0; EP: -$1,727.7; THD: -$1,105.7). At endline, DD experienced the highest decrease in adjusted serum phosphorus (DD: -0.32; EP: +0.16; THD: +0.04 mg/dL), no difference in quality-adjusted life-years (QALY), and the highest societal costs. DD had a cost-effectiveness ratio of $7,853.6 per 1 mg decrease in phosphorus, compared with EP; and was dominated by THD. Regarding QALY, DD was dominated by EP and THD. The results were sensitive to changes in key parameters.

LIMITATIONS

The analysis depended on numerous assumptions. Interpreting the results is limited by the significant baseline differences in key parameters, suggestive of higher baseline societal costs in DD.

CONCLUSIONS

DD yielded the greatest effectiveness and decrease in societal costs, but did not affect QALY. Regarding serum phosphorus, DD was likely to be cost-effective compared with EP, but had a low cost-effectiveness probability compared with THD. Regarding QALY, DD was not likely to be cost-effective. Assessing the long-term cost-effectiveness of DD, on similar groups, is recommended.

摘要

目的

评估由专业营养师(DD)开展营养教育对血液透析患者高磷血症管理的成本效益。

材料与方法

这是一项在黎巴嫩12个医院科室进行的基于试验的经济评估。总共545例现患患者被整群随机分为专业营养师组、经过培训的医院营养师组(THD)和常规治疗组(EP)。在第一阶段(6个月),专业营养师组(n = 116)接受由接受过肾脏营养培训的专业营养师进行的强化教育,经过培训的医院营养师组(n = 299)接受经过培训的医院营养师的护理,常规治疗组(n = 130)接受未经培训的医院营养师的常规护理。在第二阶段(6个月)对患者进行随访。

结果

基线时,常规治疗组每周血液透析时间最短,专业营养师组血清磷和营养不良 - 炎症评分最高。与社会成本相比,干预的额外成本较低(专业营养师组:76.7美元,21,007.7美元;常规治疗组:4.6美元,18,675.4美元;经过培训的医院营养师组:17.4美元,20,078.6美元)。在第一阶段和第二阶段之间,专业营养师组的服务使用和社会成本下降幅度最大(专业营养师组:-2,364.0美元;常规治疗组:-1,727.7美元;经过培训的医院营养师组:-1,105.7美元)。在研究结束时,专业营养师组调整后的血清磷下降幅度最大(专业营养师组:-0.32;常规治疗组:+0.16;经过培训的医院营养师组:+0.04mg/dL),质量调整生命年(QALY)无差异,社会成本最高。与常规治疗组相比,专业营养师组每降低1mg磷的成本效益比为7,853.6美元;且被经过培训的医院营养师组主导。关于QALY,专业营养师组被常规治疗组和经过培训的医院营养师组主导。结果对关键参数的变化敏感。

局限性

分析依赖于众多假设。由于关键参数存在显著的基线差异,这表明专业营养师组的基线社会成本较高,因此对结果的解释受到限制。

结论

专业营养师组产生了最大的效果并降低了社会成本,但未影响QALY。关于血清磷,与常规治疗组相比,专业营养师组可能具有成本效益,但与经过培训的医院营养师组相比,其成本效益概率较低。关于QALY,专业营养师组不太可能具有成本效益。建议对相似群体评估专业营养师组的长期成本效益。

相似文献

1
Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial.黎巴嫩血液透析患者中由专业营养师管理高磷血症的成本效益:骨营养不良管理营养教育试验的结果
J Med Econ. 2017 Oct;20(10):1024-1038. doi: 10.1080/13696998.2017.1347877. Epub 2017 Jul 13.
2
Effect of stage-based education provided by dedicated dietitians on hyperphosphataemic haemodialysis patients: results from the Nutrition Education for Management of Osteodystrophy randomised controlled trial.由专门营养师提供的基于阶段的教育对高磷血症血液透析患者的影响:来自营养教育管理骨营养不良随机对照试验的结果。
J Hum Nutr Diet. 2017 Oct;30(5):554-562. doi: 10.1111/jhn.12472. Epub 2017 Mar 21.
3
Nutritional education for management of osteodystrophy: Impact on serum phosphorus, quality of life, and malnutrition.营养教育对骨营养不良的管理:对血清磷、生活质量和营养不良的影响。
Hemodial Int. 2016 Jul;20(3):432-40. doi: 10.1111/hdi.12405. Epub 2016 Feb 3.
4
Effect of behavioral stage-based nutrition education on management of osteodystrophy among hemodialysis patients, Lebanon.基于行为阶段的营养教育对黎巴嫩血液透析患者骨营养不良管理的影响。
Patient Educ Couns. 2015 Sep;98(9):1116-22. doi: 10.1016/j.pec.2015.05.005. Epub 2015 May 29.
5
Nutritional education for management of osteodystrophy (NEMO) trial: Design and patient characteristics, Lebanon.营养教育治疗骨营养不良症(NEMO)试验:设计和患者特征,黎巴嫩。
Nutr Res Pract. 2014 Feb;8(1):103-11. doi: 10.4162/nrp.2014.8.1.103. Epub 2014 Jan 29.
6
Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients.营养师参与由透析工作人员主导的血液透析患者高磷血症控制饮食教育的额外益处。
Clin Exp Nephrol. 2016 Oct;20(5):815-821. doi: 10.1007/s10157-015-1212-1. Epub 2015 Dec 11.
7
A societal cost-of-illness study of hemodialysis in Lebanon.黎巴嫩血液透析的社会疾病成本研究。
J Med Econ. 2016 Dec;19(12):1157-1166. doi: 10.1080/13696998.2016.1207653. Epub 2016 Jul 14.
8
Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.碳酸镧治疗透析患者高磷血症的成本效果分析:一个加拿大支付方视角。
Clin Ther. 2012 Jul;34(7):1531-43. doi: 10.1016/j.clinthera.2012.06.006. Epub 2012 Jun 27.
9
A modeled economic evaluation of sevelamer for treatment of hyperphosphatemia associated with chronic kidney disease among patients on dialysis in the United Kingdom.在英国,对接受透析治疗的慢性肾脏病患者中与高磷血症相关的西那卡塞进行建模经济评估。
J Med Econ. 2013;16(1):1-9. doi: 10.3111/13696998.2012.718019. Epub 2012 Sep 10.
10
Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.一线司维拉姆和碳酸镧与钙基结合剂治疗慢性肾脏病高磷血症的成本效益
Value Health. 2018 Mar;21(3):318-325. doi: 10.1016/j.jval.2017.08.3020. Epub 2017 Oct 18.

引用本文的文献

1
Impact of Nutrition Education on Various Health-Related Components of Hemodialysis Patients: A Systematic Review.营养教育对血液透析患者各种健康相关指标的影响:一项系统综述
Healthcare (Basel). 2024 Jun 14;12(12):1197. doi: 10.3390/healthcare12121197.
2
Interventions for improving health literacy in people with chronic kidney disease.干预措施以提高慢性肾脏病患者的健康素养。
Cochrane Database Syst Rev. 2022 Dec 6;12(12):CD012026. doi: 10.1002/14651858.CD012026.pub2.
3
A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa.
中东和北非地区诊断与治疗干预措施经济评估研究的系统评价
Appl Health Econ Health Policy. 2022 May;20(3):315-335. doi: 10.1007/s40258-021-00703-y. Epub 2021 Dec 21.
4
Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis.维持性血液透析患者磷特异性饮食治疗对血磷水平的影响:系统评价和荟萃分析。
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):107-120. doi: 10.2215/CJN.09360620.
5
DAXX mediates high phosphate-induced endothelial cell apoptosis in vitro through activating ERK signaling.DAXX通过激活ERK信号通路在体外介导高磷诱导的内皮细胞凋亡。
PeerJ. 2020 Jun 19;8:e9203. doi: 10.7717/peerj.9203. eCollection 2020.
6
Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs?高磷血症管理的患者教育:改善治疗效果并降低成本?
Kidney Res Clin Pract. 2018 Mar;37(1):4-7. doi: 10.23876/j.krcp.2018.37.1.4. Epub 2018 Mar 31.